A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants
Status:
Completed
Trial end date:
2016-02-12
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy, pharmacokinetics (PK), and safety of
icatibant for the treatment of acute attacks in Japanese participants with type I or type II
hereditary angioedema (HAE).